Vitamin B6: a molecule for human health?

Washington State University, Abelson 435, P.O. Box 66224, Pullman, WA, USA.
Molecules (Impact Factor: 2.1). 01/2010; 15(1):442-59. DOI: 10.3390/molecules15010442
Source: PubMed

ABSTRACT Vitamin B6 is an intriguing molecule that is involved in a wide range of metabolic, physiological and developmental processes. Based on its water solubility and high reactivity when phosphorylated, it is a suitable co-factor for many biochemical processes. Furthermore the vitamin is a potent antioxidant, rivaling carotenoids or tocopherols in its ability to quench reactive oxygen species. It is therefore not surprising that the vitamin is essential and unquestionably important for the cellular metabolism and well-being of all living organisms. The review briefly summarizes the biosynthetic pathways of vitamin B6 in pro- and eukaryotes and its diverse roles in enzymatic reactions. Finally, because in recent years the vitamin has often been considered beneficial for human health, the review will also sum up and critically reflect on current knowledge how human health can profit from vitamin B6.

1 Follower
  • [Show abstract] [Hide abstract]
    ABSTRACT: Pyridoxal 5'-phosphate (PLP; a B6 vitamer) serves as an important cofactor in a myriad of metabolic reactions, including the transsulfuration (TS) pathway, which converts homocysteine (Hcy) to cysteine. While overt vitamin B6 deficiency is rare, moderate deficiency is common and may be exacerbated by anti-pyridoxine factors in the food supply. To this end, we developed a model of moderate B6 deficiency and a study was conducted to examine the in vivo effect of 1-amino d-proline (1ADP), an anti-pyridoxine factor found in flaxseed, on indices of Hcy metabolism through the TS pathway in moderately B6 deficient rats. Male weaning rats received a semi-purified diet containing either 7mg/kg (control; CD) or 0.7mg/kg (moderately deficient; MD) diet of pyridoxine·hydrochloride (PN∙HCl), each with 1 of 4 levels of 1ADP, viz. 0, 0.1, 1 and 10mg/kg diet for 5weeks. Perturbations in vitamin B6 biomarkers were more pronounced in the MD group. Plasma PLP was significantly reduced, while plasma Hcy (8-fold) and cystathionine (11-fold) were increased in rats consuming the highest amount of 1ADP in the MD group. The activities of hepatic cystathionine β-synthase and cystathionine γ-lyase enzymes were significantly reduced in rats consuming the highest 1ADP compared to the lowest, for both levels of PN∙HCl. Dilation of hepatic central veins and sinusoids, mild steatosis and increased liver triglycerides were present in MD rats consuming the highest 1ADP level. The current data provide evidence that the consumption of an anti-pyridoxine factor linked to flaxseed may pose a risk for subjects who are moderate/severe vitamin B6 deficient. Copyright © 2014 Elsevier Inc. All rights reserved.
    The Journal of Nutritional Biochemistry 12/2014; 26(3). DOI:10.1016/j.jnutbio.2014.10.014 · 4.59 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Vitamin B6 status in the body is affected by several factors including dietary supply of the antivitamin B6 factor, 1-amino D-proline (1ADP) which is present in flaxseed. Owing to the prevalence of moderate B6 deficiency in the general population, a co-insult of 1ADP exposure may lead to a further deterioration of B6 status. To this end, we applied a non-targeted metabolomics approach to identify potential plasma lipophilic biomarkers of 1ADP injury in moderately vitamin B6-deficient rats. Male weaning rats (n=6/treatment) received a semi-purified diet containing puridoxine·HCl at either 7 (optimal B6) or 0.7mg/kg diet (moderate B6), each with 0 or 10mg/kg diet of synthetic 1ADP for 5 weeks. Plasma lipophilic metabolites were extracted in acetonitrile for analysis via LC-QTOF/MS. Ten potential lipophilic-biomarkers: glycocholic acid, glycoursodeoxycholic acid, murocholic acid , N-docosahexaenoyl GABA, NarachidonoylGABA, lumula, nandrolone, orthothymotinic acid , cystamine, and 3-methyleneoxindole were identifiedout of >2500 detected entities. Changes in these metabolites revealed potential defects in the biosynthesis and metabolism of bile acids, N-acyl amino acids, analgenic androgens, anti-inflammatory and neuroprotective molecules. These data provide new insights into the impact of B6 inadequacy on pathways linked to vitamin B6 metabolism.
    Experimental Biology-2015, The FASEB journal, Boston, US; 03/2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: This study was undertaken to investigate the protective effects of vitamin B6, cofactor for cystathionine-γ lyase and cystathionine-β synthase (producers of H2S), alone and in combination with L-cysteine, H2S precursor, on indomethacin-, and ethanol-induced gastric lesions in male NMRI mice. Fasted male NMRI mice were randomly assigned into 12 groups (7 in each). The gastroprotective activity of vitamin B6 alone and in combination with L-cysteine and sodium hydrosulfate (NaHS) was evaluated against ethanol-, and indomethacin-induced gastric lesions. The animals were received vehicle, vitamin B6, L-cysteine, L-cysteine+vitamin B6, NaHS or NaHS+B6 before the induction of gastric lesions by ethanol (50%, 0.5 ml/25 g of body weight, orally) or indomethacin (40 mg/kg, orally). One and five hours after the administration of ethanol and indomethacin, respectively, the animals were sacrificed using anesthetics. The stomachs were removed, rinsed with normal saline and assessed for gastric wall mucus changes. Pretreatment with L-cysteine, sodium hydrosulfate, and vitamin B6 significantly decreased the total area of gastric lesions (P<0.01). The mucus production in L-cysteine-, sodium hydrosulfate-, and vitamin B6-treated animals were significantly higher than in control rats P<0.05). The gastroprotective activity of L-cysteine and sodium hydrosulfate in combination with vitamin B6 were higher than when administered alone (P<0.05). The result of this survey showed that the protective activity of L-cysteine and sodium hydrosulfate enhances in the presence of vitamin B6.
    Iranian Journal of Basic Medical Science 03/2015; 18(3):253-8. · 0.60 Impact Factor


1 Download
Available from